Summaries by Inventor Kipnis, Jonathan

Effector CAR T-Cells for Treatment of Alzheimer’s Disease
Boskovic, Pavle ; Kipnis, Jonathan
T-020995

— Published Date: 5/14/2025 Value proposition: Using CAR T-cells to treat Alzheimer’s disease and other neurodegenerative diseases through Ab-specific activation. Technology Description While CD4+ (helper or effector) T-cells play complex roles in the pathophysiology of Alzheimer’s …

“Guardian” Brain Peptides as Autoimmune Therapeutic
Kim, Min Woo "Mitch" ; Kipnis, Jonathan
T-020431

— Published Date: 5/13/2025 Value proposition: New therapeutic modality that uses CNS self-peptides to treat autoimmune diseases, reducing neuroinflammation damage in an organ-specific manner. Technology Description Autoimmune diseases continue to debilitate countless individuals, increasing healt…

Engineered transient autoimmune (ETA) T cell therapy for CNS injury
Kipnis, Jonathan
T-019788

— Published Date: 5/13/2025 Value Proposition: Promotion of recovery and reduction of neuronal damage following nerve injury, first T cell approach to neurological disorders. Technology Description Traumatic injuries to the spinal cord or the brain currently have limited treatment options, particu…